Inventor
KAY-GUNNAR STUBENRAUCH
Inventor
DE
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides33%
G01NInvestigating or analysing materials by determining their chemical or physical properties28%
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C12NMicroorganisms or enzymes6%
PatentTitleYear
12,291,561Antigen binding receptors specific for mutated Fc domains202511,970,550Anti-variant Fc-region antibodies and method of use202411,913,945Method for determining the amount of a therapeutic antibody in the brain202411,679,127Antigen binding receptors specific for mutated Fc domains202311,561,229Immunoassay for the determination of Fc-region modified antibodies202311,340,234Method for the determination of anti-drug antibodies against an effector function suppressed human or humanized drug antibody202211,313,864Method for determining anti-drug antibodies in a minipig sample202211,242,390Protease-activated T cell bispecific molecules2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to HOFFMANN LA ROCHE (8)· patent assignee history
2022–2025Based in DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOFFMANN LA ROCHE | 8 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 8 | 2022–2025 |